Brief: Propanc Biopharma Pursues Strategic Acquisition of DAT Firms Trading Below Market Cap To Net Asset Value
04/11/2025 12:26
Nov 4 (Reuters) - Propanc Biopharma Inc PPCB.O: PROPANC BIOPHARMA, INC. PURSUES STRATEGIC ACQUISITION PLAN TARGETING DIGITAL ASSET TREASURY (DAT) COMPANIES TRADING BELOW MARKET CAP TO NET ASSET VALUE (MNAV) Source text: ID:nGNX4sKhrQ Further company coverage: PPCB.O ((Reuters.Briefs@thomsonreuters.com;))